Cervellati C - Search Results

1

Serum Apo J as a potential marker of conversion from mild cognitive impairment to dementia.

Romagnoli T, Ortolani B, Sanz JM, Trentini A, Seripa D, Nora ED, Capatti E, Cervellati C, Passaro A, Zuliani G, Brombo G. Romagnoli T, et al. Among authors: cervellati c. J Neurol Sci. 2021 Aug 15;427:117537. doi: 10.1016/j.jns.2021.117537. Epub 2021 Jun 15. J Neurol Sci. 2021. PMID: 34147956

2

Systemic oxidative stress in older patients with mild cognitive impairment or late onset Alzheimer's disease.

Cervellati C, Cremonini E, Bosi C, Magon S, Zurlo A, Bergamini CM, Zuliani G. Cervellati C, et al. Curr Alzheimer Res. 2013 May 1;10(4):365-72. doi: 10.2174/1567205011310040003. Curr Alzheimer Res. 2013. PMID: 22950912

3

Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia.

Cervellati C, Romani A, Seripa D, Cremonini E, Bosi C, Magon S, Passaro A, Bergamini CM, Pilotto A, Zuliani G. Cervellati C, et al. J Neurol Sci. 2014 Feb 15;337(1-2):156-61. doi: 10.1016/j.jns.2013.11.041. Epub 2013 Dec 4. J Neurol Sci. 2014. PMID: 24321755

4

Systemic oxidative stress and conversion to dementia of elderly patients with mild cognitive impairment.

Cervellati C, Romani A, Seripa D, Cremonini E, Bosi C, Magon S, Bergamini CM, Valacchi G, Pilotto A, Zuliani G. Cervellati C, et al. Biomed Res Int. 2014;2014:309507. doi: 10.1155/2014/309507. Epub 2014 Jan 12. Biomed Res Int. 2014. PMID: 24524075 Free PMC article.

5

Serum ferroxidase activity in patients with multiple sclerosis: a pilot study.

Cervellati C, Romani A, Fainardi E, Trentini A, Squerzanti M, Baldi E, Caniatti ML, Granieri E, Bellini T, Castellazzi M. Cervellati C, et al. In Vivo. 2014 Nov-Dec;28(6):1197-200. In Vivo. 2014. PMID: 25398823

6

PON-1 and ferroxidase activities in older patients with mild cognitive impairment, late onset Alzheimer's disease or vascular dementia.

Cervellati C, Romani A, Bergamini CM, Bosi C, Sanz JM, Passaro A, Zuliani G. Cervellati C, et al. Clin Chem Lab Med. 2015 Jun;53(7):1049-56. doi: 10.1515/cclm-2014-0803. Clin Chem Lab Med. 2015. PMID: 25490030

7

Serum levels of hydroperoxides and multimorbidity among older patients with mild cognitive impairment or late-onset Alzheimer's disease.

Cervellati C, Romani A, Bosi C, Magon S, Passaro A, Bergamini CM, Zuliani G. Cervellati C, et al. Aging Clin Exp Res. 2015 Dec;27(6):799-804. doi: 10.1007/s40520-015-0352-1. Epub 2015 Mar 21. Aging Clin Exp Res. 2015. PMID: 25795344

8

Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: A pilot study.

Cervellati C, Trentini A, Romani A, Bellini T, Bosi C, Ortolani B, Zurlo A, Passaro A, Seripa D, Zuliani G. Cervellati C, et al. J Neurochem. 2015 Oct;135(2):395-401. doi: 10.1111/jnc.13240. Epub 2015 Aug 3. J Neurochem. 2015. PMID: 26178739 Free article.

9

Oxidative challenge in Alzheimer's disease: state of knowledge and future needs.

Cervellati C, Wood PL, Romani A, Valacchi G, Squerzanti M, Sanz JM, Ortolani B, Zuliani G. Cervellati C, et al. J Investig Med. 2016 Jan;64(1):21-32. doi: 10.1136/jim-2015-000017. J Investig Med. 2016. PMID: 26755810 Review.

10

Targeted lipidomics distinguishes patient subgroups in mild cognitive impairment (MCI) and late onset Alzheimer's disease (LOAD).

Wood PL, Locke VA, Herling P, Passaro A, Vigna GB, Volpato S, Valacchi G, Cervellati C, Zuliani G. Wood PL, et al. Among authors: cervellati c. BBA Clin. 2015 Nov 14;5:25-8. doi: 10.1016/j.bbacli.2015.11.004. eCollection 2016 Jun. BBA Clin. 2015. PMID: 27051586 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

163 results

Search Page

Filters